Thu0584 rheumatological Immune-Related Adverse Events Associadted With Immunotherapy in Solid Organ Tumor. Study of 102 Cases From a Referral Single Center for Last 4 Years
Abstract:BackgroundImmune checkpoint blockade therapy (ICBT) currently is one of the most used therapies against cancer. The activation of the immune system can lead to different immune-related adverse events (irAEs), being the rheumatological side effects among the most common.ObjectivesOur aim was to assess the rheumatological irAEs in patients who received immunotherapy.MethodsWe set up an observational study of patients treated with Nivolumab and Pembrolizumab (anti-PD1), Atezolizumab (anti-PD-L1) and Ipilimumab (a… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.